Next events

No event to show.

Previous events

Nov 11, 2019

BIO-Europe Fall 2019, November 11-13 Hamburg

Edmond Godfroid, CEO and Ludwig Camusot, business developer will represent Bioxodes at BIO-Europe Fall 2019.

BIO-Europe Fall 2019



Jul 7, 2019

Poster presentation:

Abstract Title: “Ir-CPI, a FXI/FXIIa inhibitor, provides an effective and safe thromboprotection during extracorporeal circulation associated with open-heart surgery”.

Presentation number: PB0051


Poster ISTH 2019


Melbourne, Australia

Jul 19, 2018

Poster presentation:

Abstract presentation number: PB503 - "Ir-CPI: an original inhibitor of thrombosis and thrombosis-associated with cancer"

Poster ISTH 2018.pdf

Oral presentation:

"Ir-CPI a New Potent Inhibitor of Thrombosis and Thrombosis Associated with Cancer"


Dublin, Ireland

Jul 19, 2018

Oral presentation:

"Ir-CPI: an original inhibitor of thrombosis and thrombosis associated with cancer"


Dublin, Ireland

Jul 10, 2017

Abstract Title: "Efficacy of a Novel Contact Pathway Inhibitor, Ir-CPI, on in vitro Clotting Induced by PCI Catheter Segment"


Poster ISTH 2017.pdf

Berlin, Germany

May 1, 2016

Bioxodes to participate at the ISTH SCC 2016 annual congress.

Montpellier, France

Jun 1, 2015

Abstract titles : 
“Efficacy of a novel contact pathway inhibitor, Ir-CPI, in an extracorporeal membrane oxygenator model” ECMO 2015.pdf
“Antithrombotic effects of Ir-CPI in an arterio-venous shunt model in the rabbit” AV-shunt 2015.pdf
“Evaluation of the effects of a novel contact pathway inhibitor, Ir-CPI, on in vitro platelet function and coagulation” Platelets 2015.pdf

Toronto, Canada